1. Home
  2. FPAY vs INKT Comparison

FPAY vs INKT Comparison

Compare FPAY & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FPAY
  • INKT
  • Stock Information
  • Founded
  • FPAY 2003
  • INKT 2017
  • Country
  • FPAY United States
  • INKT United States
  • Employees
  • FPAY N/A
  • INKT N/A
  • Industry
  • FPAY Diversified Commercial Services
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • FPAY Consumer Discretionary
  • INKT Health Care
  • Exchange
  • FPAY Nasdaq
  • INKT Nasdaq
  • Market Cap
  • FPAY 31.0M
  • INKT 31.2M
  • IPO Year
  • FPAY N/A
  • INKT 2021
  • Fundamental
  • Price
  • FPAY $1.36
  • INKT $7.50
  • Analyst Decision
  • FPAY Strong Buy
  • INKT Strong Buy
  • Analyst Count
  • FPAY 2
  • INKT 2
  • Target Price
  • FPAY $3.25
  • INKT $37.50
  • AVG Volume (30 Days)
  • FPAY 46.0K
  • INKT 3.7K
  • Earning Date
  • FPAY 05-20-2025
  • INKT 05-15-2025
  • Dividend Yield
  • FPAY N/A
  • INKT N/A
  • EPS Growth
  • FPAY N/A
  • INKT N/A
  • EPS
  • FPAY N/A
  • INKT N/A
  • Revenue
  • FPAY $139,800,732.00
  • INKT N/A
  • Revenue This Year
  • FPAY $12.05
  • INKT N/A
  • Revenue Next Year
  • FPAY N/A
  • INKT N/A
  • P/E Ratio
  • FPAY N/A
  • INKT N/A
  • Revenue Growth
  • FPAY 19.51
  • INKT N/A
  • 52 Week Low
  • FPAY $0.97
  • INKT $4.56
  • 52 Week High
  • FPAY $2.37
  • INKT $13.79
  • Technical
  • Relative Strength Index (RSI)
  • FPAY 54.81
  • INKT 48.04
  • Support Level
  • FPAY $1.31
  • INKT $6.34
  • Resistance Level
  • FPAY $1.43
  • INKT $7.76
  • Average True Range (ATR)
  • FPAY 0.09
  • INKT 0.58
  • MACD
  • FPAY 0.01
  • INKT 0.03
  • Stochastic Oscillator
  • FPAY 50.00
  • INKT 69.46

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: